Drug Exposure and Safety of a Shorter Tuberculosis Treatment Based on High-Dose Rifampicin and Pyrazinamide
Clinical trial NCT04694586 · SUSPENDED
Trial details
- NCT number
- NCT04694586
- Sponsor
- University Hospital, Linkoeping
- Status
- SUSPENDED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-30
- Primary completion
- 2029-05-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.